Yousef Baghcheghi

Dr. Yousef Baghcheghi

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2025 in Cellular and Molecular Neurobiology
Verified
Journal Article
Open access
HMHabibeh Mashayekhi-Sardoo
Habibeh Mashayekhi-Sardoo
FRFateme Razazpour
Fateme Razazpour
ZHZohreh Hakemi
Zohreh Hakemi
MHMahdiyeh Hedayati-Moghadam
Mahdiyeh Hedayati-Moghadam
YBYousef Baghcheghi
Yousef Baghcheghi
Ethanol consumption is widely recognized for its detrimental effects on mental health, particularly its association with depressive disorders. This narrative review aims to explore the intricate molecular mechanisms underlying ethanol-induced depression, synthesizing findings from preclinical and clinical studies. We begin by providing an overview of the relationship between chronic ethanol consumption and depression, highlighting compelling evidence from diverse populations. Subsequently, we delve into insights from animal models that elucidate the pathophysiological changes triggered by prolonged ethanol exposure. Key mechanisms identified include oxidative stress, which contributes to cellular damage; neuroinflammation, characterized by the activation of glial cells and altered cytokine profiles; and disruptions in neurotrophic factors that impair neuronal growth and survival. Furthermore, we discuss the induction of apoptosis in neural cells and the significant impact of ethanol on neurotransmitter receptor remodeling and regulation, leading to altered synaptic transmission. While substantial progress has been made in understanding these mechanisms, we also acknowledge the limitations of current research methodologies and call for further investigations to translate these findings into effective therapeutic strategies for individuals affected by ethanol-induced depression. This review ultimately underscores the need for a comprehensive understanding of the molecular underpinnings of ethanol's impact on mood disorders, paving the way for improved interventions and preventative measures.

25 June 2024 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MHMahdiyeh Hedayati-Moghadam
Mahdiyeh Hedayati-Moghadam
FRFateme Razazpour
Fateme Razazpour
MPMohammad Pourfridoni
Mohammad Pourfridoni
FMFaezeh Mirzaee
Faezeh Mirzaee
YBYousef Baghcheghi
Yousef Baghcheghi

6 February 2026 in Journal of Alzheimer's Disease Reports
Verified
Journal Article
Open access
ZBZahra Behroozi
Zahra Behroozi
HAHedyeh Askarpour
Hedyeh Askarpour
YBYousef Baghcheghi
Yousef Baghcheghi
This narrative review aims to synthesize and critically evaluate the complex molecular mechanisms by which amyloid-β (Aβ) accumulation disrupts hippocampal synaptic plasticity, the cellular cornerstone of learning and memory in Alzheimer's disease (AD). AD is characterized by progressive hippocampus-dependent cognitive decline, strongly linked to impaired synaptic plasticity, the cellular basis of learning and memory. This review deciphers how Aβ accumulation orchestrates synaptic sabotage in the hippocampus. We detail the core molecular machinery of hippocampal synaptic plasticity, emphasizing glutamate receptor trafficking (NMDAR/AMPAR), Ca 2+ signaling, and neurotrophin pathways (BDNF/TrkB). Central to AD pathogenesis, soluble Aβ oligomers initiate synaptic dysfunction by targeting receptors like PrPᶜ/mGluR5, triggering NMDAR overactivation (via Fyn/NR2B) and AMPAR endocytosis. Aβ further drives tau hyperphosphorylation (via GSK-3β/CDK5), leading to dendritic p-tau accumulation and destabilization of the postsynaptic density (PSD). Concurrently, Aβ activates microglia (via TLR4/TREM2) and astrocytes, promoting neuroinflammation (IL-1β, TNF-α, C1q) and complement-mediated synaptic phagocytosis. Aβ-induced oxidative stress (ROS/RNS, lipid peroxidation) and mitochondrial failure (mPTP opening, energy depletion) exacerbate Ca 2+ dyshomeostasis and plasticity impairment. Critically, Aβ disrupts BDNF/TrkB signaling, promoting proBDNF/p75ᴺᵀᴿ-mediated spine loss and inhibiting CREB-dependent plasticity gene expression. These converging pathways—glutamate receptor dysregulation, p-tau toxicity, neuroinflammation, oxidative stress, mitochondrial dysfunction, and neurotrophic collapse—culminate in synaptic apoptosis, profound structural damage (spine loss, PSD dissolution), and functional deficits (long-term potentiation (LTP) blockade, enhanced long-term depression (LTD)). This molecular cascade directly underlies hippocampal circuit failure and cognitive decline in AD. Future research must address Aβ strain specificity, regional vulnerability, glial metabolic coupling, resilience mechanisms, and novel therapeutic strategies targeting these pathways.

1 October 2025 in Physiology & Behavior
Verified
Journal Article
Closed access
AGAhmad Golkar
Ahmad Golkar
FRFateme Razazpour
Fateme Razazpour
MDMohammad Dalfardi
Mohammad Dalfardi
YBYousef Baghcheghi
Yousef Baghcheghi

28 February 2025 in NeuroToxicology
Verified
Journal Article
Closed access
HMHabibeh Mashayekhi-Sardoo
Habibeh Mashayekhi-Sardoo
MHMahdiyeh Hedayati-Moghadam
Mahdiyeh Hedayati-Moghadam
YBYousef Baghcheghi
Yousef Baghcheghi

10 May 2024 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MPMohammad Pourfridoni
Mohammad Pourfridoni
MHMahdiyeh Hedayati-Moghadam
Mahdiyeh Hedayati-Moghadam
SFShirin Fathi
Shirin Fathi
SFShiva Fathi
Shiva Fathi
FMFatemeh Sadat Mirrashidi
Fatemeh Sadat Mirrashidi
YBYousef Baghcheghi
Yousef Baghcheghi